Search results
Results From The WOW.Com Content Network
The Mazda CX-7 is a mid-size crossover SUV from Mazda, and is the production version of the MX-Crossport concept car. It was shown publicly for the first time at the 2006 LA Auto Show in January. Production officially began on February 20, 2006 in Mazda's Ujina #2 factory in Hiroshima , and went on sale in April 2006 as a 2007 model.
Mazda is issuing recalls for over 150,000 vehicles, including Mazda CX-70 and CX-90 models. The automotive manufacturer recalls 80,915 of its 2024-2025 CX-90 and 2025 CX-70 vehicles equipped with ...
Many suspension and braking components are interchangeable with the RX-8, while some interior components are shared with the Mazda6, Mazda3 and CX-7. ND Mazda MX-5 / Mazda Roadster / Mazda MX-5 Miata: 2016–present: ND uses a new platform for the fourth generation of the MX-5. NF Fiat 124 Spider / Abarth 124 Spider / Abarth 124 GT [15] 2017–2020
Mazda CX-80 (mid-size crossover SUV sold exclusively outside North America, 2024–present) Mazda CX-9 (mid-size crossover SUV sold exclusively outside Japan, 2006–2024) Mazda CX-90 (large crossover SUV sold exclusively in North America, Australia, the Middle East, Hong Kong, and the Philippines, [ 4 ] [ 5 ] [ 6 ] 2023–present)
Mazda Motor Corporation (マツダ株式会社, Matsuda Kabushiki gaisha) is a Japanese multinational automotive manufacturer headquartered in Fuchū, Hiroshima, Japan. [5] The company was founded on January 30, 1920, as Toyo Cork Kogyo Co., Ltd., a cork-making factory, by Jujiro Matsuda.
Which cars are included in the Ford recall? 2021-2023 Ford Bronco Sport. 2022-2023 Mavericks. What to do if you have a recalled car.
Product recalls are one of a number of corrective actions that can be taken for products that are deemed to be unsafe. The recall is an effort to limit ruination of the corporate image and limit liability for corporate negligence, which can cause significant legal costs. It can be difficult, if not impossible, to determine how costly can be ...
The FDA said the recall of the device BioZorb Marker, initiated by Hologic in March, was not a product removal, but a correction. The agency also urged patients to report any side effects they ...